1. Home
  2. ALAR vs TENX Comparison

ALAR vs TENX Comparison

Compare ALAR & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alarum Technologies Ltd.

ALAR

Alarum Technologies Ltd.

HOLD

Current Price

$6.30

Market Cap

58.8M

Sector

Technology

ML Signal

HOLD

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$15.71

Market Cap

56.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALAR
TENX
Founded
2013
1967
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.8M
56.2M
IPO Year
2018
2001

Fundamental Metrics

Financial Performance
Metric
ALAR
TENX
Price
$6.30
$15.71
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$14.00
$29.67
AVG Volume (30 Days)
39.3K
391.5K
Earning Date
03-19-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$33.30
N/A
Revenue Next Year
$30.53
N/A
P/E Ratio
$44.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.45
$4.64
52 Week High
$18.00
$18.38

Technical Indicators

Market Signals
Indicator
ALAR
TENX
Relative Strength Index (RSI) 43.10 61.59
Support Level N/A $12.71
Resistance Level $7.76 $16.27
Average True Range (ATR) 0.44 1.30
MACD -0.04 0.15
Stochastic Oscillator 30.77 73.73

Price Performance

Historical Comparison
ALAR
TENX

About ALAR Alarum Technologies Ltd.

Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

Share on Social Networks: